Efficacy, Safety, And Pharmacokinetics Of Rifaximin In Subjects With Severe Hepatic Impairment And Hepatic Encephalopathy
Public ClinicalTrials.gov record NCT01846663. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial To Evaluate The Efficacy, Safety, And Pharmacokinetics Of Rifaximin 550 Mg In Subjects With Severe Hepatic Impairment And Overt Hepatic Encephalopathy
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of the study is to evaluate the safety of Rifaximin or placebo in subjects with severe hepatic impairment and Hepatic Encephalopathy.
Study identification
- NCT ID
- NCT01846663
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 4
- Enrollment
- 6 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Apr 2, 2013
- Primary completion
- Feb 21, 2016
- Completion
- Feb 21, 2016
- Last update posted
- Jan 8, 2024
2013 – 2016
United States locations
- U.S. sites
- 28
- U.S. states
- 17
- U.S. cities
- 25
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| The University of Alabama at Birmingham | Birmingham | Alabama | 35294-0111 | — |
| Banner Research | Phoenix | Arizona | 85016 | — |
| University Of Arizona Liver Research Institute | Tucson | Arizona | 85724 | — |
| Southern California Liver Centers | Coronado | California | 92118 | — |
| UCSD Clinical & Translational Research Institute | La Jolla | California | 92037 | — |
| Loma Linda University Medical Center Transplantation Institute | Loma Linda | California | 92324 | — |
| University of Southern Califorina Keck School Of Medicine | Los Angeles | California | 90033 | — |
| Cedars-Sinai Medical Center | Los Angeles | California | 90048 | — |
| Inland Empire Liver Foundation | Rialto | California | 92377 | — |
| University of Colorado Denver | Aurora | Colorado | 80045 | — |
| Salix Site | New Haven | Connecticut | 06520 | — |
| Salix Site | Tampa | Florida | 33606 | — |
| Piedmont Atlanta Hospital | Atlanta | Georgia | 30309 | — |
| Northwestern University-Comprehensive Transplant Center | Chicago | Illinois | 60611 | — |
| Rush University Medical Center | Chicago | Illinois | 60612 | — |
| Tulane Abdominal Transplant Research Office | New Orleans | Louisiana | 70112 | — |
| Mayo Clinic | Rochester | Minnesota | 55905 | — |
| Washington University | St Louis | Missouri | 63110 | — |
| New York University School of Medicine | New York | New York | 10016 | — |
| Salix Site | Portland | Oregon | 97239 | — |
| Vanderbilt University Medical Center | Nashville | Tennessee | 37212-1610 | — |
| The Liver Institute at Methodist Dallas Medical Center | Dallas | Texas | 75203 | — |
| Brook Army Medical Center | Fort Sam Houston | Texas | 78234 | — |
| Salix Site | Galveston | Texas | 77555 | — |
| The Methodist Hospital | Houston | Texas | 77030 | — |
| McGuire VA Medical Center | Richmond | Virginia | 23249 | — |
| VCU/MCV Health Systems | Richmond | Virginia | 23298 | — |
| Swedish Medical Center | Seattle | Washington | 98122 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01846663, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jan 8, 2024 · Synced Sep 10, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT01846663 live on ClinicalTrials.gov.